Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oh

Showing results (481-490 of 552) with videos related to

Pageof 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FBrady L Stein, Stephen T Oh, Dmitriy Berenzon, et al.
Leukemia & Lymphoma|March 7, 2022
Momelotinib reduces transfusion requirements in patients with myelofibrosisRuben Mesa, Stephen T Oh, Aaron T Gerds, et al.
The Journal of Biological Chemistry|September 3, 1999
Crystal structure of a maltogenic amylase provides insights into a catalytic versatilityJ S Kim, S S Cha, H J Kim, et al.
Blood Advances|April 12, 2023
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trialsSrdan Verstovsek, Ruben Mesa, Vikas Gupta, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2026
Does Pacemaker Mode Affect Outcomes in Patients With HeartMate 3 LVAD?Boaz Elad, Dor Lotan, Brian LaBarre, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Clinical Transplantation|July 18, 2024
Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart TransplantationElena M Donald, Elissa Driggin, Jason Choe, et al.
The Review of Scientific Instruments|July 2, 2010
Diagnostics for first plasma and development plan on KSTARJ H Lee, H K Na, S G Lee, et al.
Cancer Cell|November 14, 2018
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor CellsHamza Celik, Won Kyun Koh, Ashley C Kramer, et al.
The Journal of Experimental Medicine|March 23, 2019
PIP4K2A as a negative regulator of PI3K in PTEN<i>-</i>deficient glioblastomaYong Jae Shin, Jason K Sa, Yeri Lee, et al.
Pageof 56

Showing results (481-490 of 552) with videos related to

Sort By:
Pageof 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FBrady L Stein, Stephen T Oh, Dmitriy Berenzon, et al.
Leukemia & Lymphoma|March 7, 2022
Momelotinib reduces transfusion requirements in patients with myelofibrosisRuben Mesa, Stephen T Oh, Aaron T Gerds, et al.
The Journal of Biological Chemistry|September 3, 1999
Crystal structure of a maltogenic amylase provides insights into a catalytic versatilityJ S Kim, S S Cha, H J Kim, et al.
Blood Advances|April 12, 2023
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trialsSrdan Verstovsek, Ruben Mesa, Vikas Gupta, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2026
Does Pacemaker Mode Affect Outcomes in Patients With HeartMate 3 LVAD?Boaz Elad, Dor Lotan, Brian LaBarre, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Clinical Transplantation|July 18, 2024
Cardio-Renal-Metabolic Outcomes Associated With the Use of GLP-1 Receptor Agonists After Heart TransplantationElena M Donald, Elissa Driggin, Jason Choe, et al.
The Review of Scientific Instruments|July 2, 2010
Diagnostics for first plasma and development plan on KSTARJ H Lee, H K Na, S G Lee, et al.
Cancer Cell|November 14, 2018
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor CellsHamza Celik, Won Kyun Koh, Ashley C Kramer, et al.
The Journal of Experimental Medicine|March 23, 2019
PIP4K2A as a negative regulator of PI3K in PTEN<i>-</i>deficient glioblastomaYong Jae Shin, Jason K Sa, Yeri Lee, et al.
Pageof 56